Characterisation and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population

FEBS Letters

Volumn 448, Issue 1, 1999, Pages 105-110

  Oscarson, Mikael ^a   McLellan, Roman A ^a   Gullstén, Harriet ^b   Yue, Qun Ying ^c   Lang, Matti A ^d   Luisa Bernal, Maria ^e   Sinues, Blanca ^e   Hirvonen, Ari ^f   Raunio, Hannu ^b   Pelkonen, Olavi ^b   Ingelman Sundberg, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OULU   (Finland)

^c MEDICAL PRODUCTS AGENCY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e UNIVERSITY OF ZARAGOZA   (Spain)

^f FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Coumarin; Cytochrome P450; Gene deletion; Genotype; Phenotype; Unequal crossover

Indexed keywords

CARCINOGEN; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME;

ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; DRUG METABOLISM; ETHNOLOGY; FINLAND; GENE DELETION; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING; SOUTHERN BLOTTING; SPAIN;

ALLELES; ARYL HYDROCARBON HYDROXYLASES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; FINLAND; GENE DELETION; GENE FREQUENCY; GENOTYPE; HUMANS; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 0033067287     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)00359-2     Document Type: Article

References (30)

1. Gonzalez F.J., Gelboin H.V. Drug Metab. Rev. 26:1994;165-183.
2. Pelkonen, O., Raunio, H., Rautio, A., Pasanen, M. and Lang, M.A. (1997) in: Coumarins: Biology, Applications and Mode of Action (O'Kennedy, R. and Thornes, R.D., Eds.), pp. 67-92, John Wiley and Sons, Chichester.
3. Oscarson M., Gullstén H., Rautio A., Bernal M.L., Sinues B., Dahl M.-L., Stengård J.H., Pelkonen O., Raunio H., Ingelman-Sundberg M. FEBS Lett. 438:1998;201-205.
4. Messina E.S., Tyndale R.F., Sellers E.M. J. Pharmacol. Exp. Ther. 282:1997;1608-1614.
5. Cashman J.R., Park S.B., Yang Z.C., Wrighton S.A., Jacob P., Benowitz N.L. Chem. Res. Toxicol. 5:1992;639-646.
6. Nakajima M., Yamamoto T., Nunoya K., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., Kuroiwa Y. Drug Metab. Dispos. 24:1996;1212-1217.
7. Nakajima M., Yamamoto T., Nunoya K., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., Kuroiwa Y. J. Pharmacol. Exp. Ther. 277:1996;1010-1015.
8. Pianezza M.L., Sellers E.M., Tyndale R.F. Nature. 393:1998;750.
9. Rautio A., Kraul H., Kojo A., Salmela E., Pelkonen O. Pharmacogenetics. 2:1992;227-233.
10. Cholerton S., Idle M.E., Vas A., Gonzalez F.J., Idle J.R. J. Chromatogr. 575:1992;325-330.
11. Iscan M., Rostami H., Iscan M., Guray T., Pelkonen O., Rautio A. Eur. J. Clin. Pharmacol. 47:1994;315-318.
12. Hadidi H., Zahlsen K., Idle J.R., Cholerton S. Food Chem. Toxicol. 35:1997;903-907.
13. Shimada T., Yamazaki H., Guengerich F.P. Xenobiotica. 26:1996;395-403.
14. Miles J.S., Bickmore W., Brook J.D., McLaren A.W., Meehan R., Wolf C.R. Nucleic Acids Res. 17:1989;2907-2917.
15. Hoffman S.M., Fernandez-Salguero P., Gonzalez F.J., Mohrenweiser H.W. J. Mol. Evol. 41:1995;894-900.
16. Daly A.K., Brockmöller J., Broly F., Eichelbaum M., Evans W.E., Gonzalez F.J., Huang J.D., Idle J.R., Ingelman-Sundberg M., Ishizaki T., Jacqz-Aigrain E., Meyer U.A., Nebert D.W., Steen V.M., Wolf C.R., Zanger U.M. Pharmacogenetics. 6:1996;193-201.
17. Yamano S., Tatsuno J., Gonzalez F.J. Biochemistry. 29:1990;1322-1329.
18. Fernandez-Salguero P., Hoffman S.M., Cholerton S., Mohrenweiser H., Raunio H., Rautio A., Pelkonen O., Huang J.D., Evans W.E., Idle J.R., Gonzalez F.J. Am. J. Hum. Genet. 57:1995;651-660.
19. Gullstén H., Agúndez J.A., Benítez J., Laara E., Ladero J.M., Diaz-Rubio M., Fernandez-Salguero P., Gonzalez F., Rautio A., Pelkonen O., Raunio H. Pharmacogenetics. 7:1997;247-250.
20. Nunoya K., Yokoi T., Kimura K., Inoue K., Kodama T., Funayama M., Nagashima K., Funae Y., Green C., Kinoshita M., Kamataki T. Pharmacogenetics. 8:1998;239-249.
21. Johansson I., Yue Q.Y., Dahl M.L., Heim M., Säwe J., Bertilsson L., Meyer U.A., Sjöqvist F., Ingelman-Sundberg M. Eur. J. Clin. Pharmacol. 40:1991;553-556.
22. Bernal, M.L., Sinues, B., Johansson, I., McLellan, R.A., Dahl, M.-L., Ingelman-Sundberg, M. and Bertilsson, L. (1998) (submitted).
23. Satarug S., Lang M.A., Yongvanit P., Sithithaworn P., Mairiang E., Mairiang P., Pelkonen P., Bartsch H., Haswell-Elkins M.R. Cancer Epidemiol. Biomarkers Prev. 5:1996;795-800.
24. Yokoi T., Kamataki T. Pharm. Res. 15:1998;517-524.
25. Cavalli-Sforza L.L., Piazza A., Menozzi P., Mountain J. Proc. Natl. Acad. Sci. USA. 85:1988;6002-6006.
26. Ingelman-Sundberg M. Arch. Toxicol. Suppl. 19:1997;3-13.
27. Steen V.M., Molven A., Aarskog N.K., Gulbrandsen A.K. Hum. Mol. Genet. 4:1995;2251-2257.
28. Xu S., Wang Y., Roe B., Pearson W.R. J. Biol. Chem. 273:1998;3517-3527.
29. Johansson I., Lundqvist E., Bertilsson L., Dahl M.L., Sjöqvist F., Ingelman-Sundberg M. Proc. Natl. Acad. Sci. USA. 90:1993;11825-11829.
30. McLellan R.A., Oscarson M., Alexandrie A.K., Seidegård J., Evans D.A.P., Rannug A., Ingelman-Sundberg M. Mol. Pharmacol. 52:1997;958-965.